Amir Nashat
Affiliations
- Large Shareholder, Director at Camp4 Therapeutics Corp (CAMP), 2024-10-15
- at Morphic Holding Inc. (MORF), 2024-08-20
- at Scholar Rock Holding Corp (SRRK), 2024-05-13
- Large Shareholder, Director at Metacrine Inc. (MTCR), 2022-09-06
- Director at Syros Pharmaceuticals Inc. (SYRS), 2022-06-02
- Director at Fate Therapeutics Inc (FATE), 2019-08-02
- Director at Selecta Biosciences Inc (SELB), 2019-06-18
- Director at Atyr Pharma Inc (LIFE), 2018-05-17
- Director at Bind Therapeutics Inc (BIND), 2015-06-10
- Director at Receptos Inc. (RCPT), 2014-06-06
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| CAMP | $11.00 | 909,090 | $9,999,990.00 | 909,090 | 2024-10-15 | Filing |
| SRRK | $4.90 | 66,142 | $324,095.80 | 206,897 | 2022-06-22 | Filing |
| SRRK | $4.90 | 1,131,850 | $5,546,065.00 | 3,540,530 | 2022-06-22 | Filing |
| MTCR | $13.00 | 15,038 | $195,494.00 | 15,038 | 2020-09-18 | Filing |
| MTCR | $13.00 | 214,962 | $2,794,506.00 | 214,962 | 2020-09-18 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| MORF | $45.50 | 15,188 | $691,054.00 | 136,691 | 2021-05-21 | Filing |
| MORF | $45.50 | 217,107 | $9,878,368.50 | 1,953,960 | 2021-05-21 | Filing |
| FATE | $22.53 | 299 | $6,736.32 | 11,034 | 2019-08-01 | Filing |
| FATE | $22.53 | 302 | $6,805.18 | 11,333 | 2019-07-31 | Filing |
| FATE | $22.53 | 204 | $4,596.00 | 7,539 | 2019-08-01 | Filing |